Who
Fred Telling
Director
Company insider
Files Form 4 as: Director, Oragenics; Director, Cti Biopharma.
In numbers
- Trades disclosed
- 136
- Buys
- 17
- Sells
- 10
- Bought
- $868K
- Sold
- $548K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Dec 2006
- Last trade
- 12 Dec 2025
- Last filed
- 22 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Dec 2025filed 22 Jan 2026 | OGEN OragenicsBiotechnology | SEC FORM 4 Sold | $198210 at $0.9446 | filing |
| 12 Dec 2025filed 22 Jan 2026 | OGEN OragenicsBiotechnology | SEC FORM 4 Sold | $197210 at $0.94 | filing |
| 12 Dec 2025filed 15 Dec 2025 | OGEN OragenicsBiotechnology | SEC FORM 4 Sold | $197210 at $0.94 | filing |
| 11 Dec 2025filed 22 Jan 2026 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 11 Dec 2025filed 22 Jan 2026 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 11 Dec 2025filed 15 Dec 2025 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 6 Dec 2024filed 9 Dec 2024 | OGEN OragenicsBiotechnology | SEC FORM 4 Sold | $1,2953,597 at $0.36 | filing |
| 19 Sep 2024filed 20 Sep 2024 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 30 Nov 2023filed 1 Dec 2023 | OGEN OragenicsBiotechnology | SEC FORM 4 Sold | $12K3,500 at $3.57 | filing |
| 8 Aug 2023filed 10 Aug 2023 | OGEN OragenicsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 29 Jul 2022filed 2 Aug 2022 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —220,000 at $0.00 | filing |
| 23 Jun 2022filed 27 Jun 2022 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 23 Jun 2022filed 24 Jun 2022 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 17 Jun 2022filed 21 Jun 2022 | OGEN OragenicsBiotechnology | SEC FORM 4 Bought | $2,92410,084 at $0.29 | filing |
| 24 May 2022filed 25 May 2022 | OGEN OragenicsBiotechnology | SEC FORM 4 Bought | $23K78,673 at $0.29 | filing |
| 23 May 2022filed 25 May 2022 | OGEN OragenicsBiotechnology | SEC FORM 4 Bought | $1,0153,500 at $0.29 | filing |
| 20 May 2022filed 23 May 2022 | OGEN OragenicsBiotechnology | SEC FORM 4 Bought | $18K65,718 at $0.28 | filing |
| 19 May 2022filed 20 May 2022 | OGEN OragenicsBiotechnology | SEC FORM 4 Bought | $16K56,806 at $0.28 | filing |
| 18 May 2022filed 20 May 2022 | OGEN OragenicsBiotechnology | SEC FORM 4 Bought | $3,97915,303 at $0.26 | filing |
| 31 Mar 2022filed 1 Apr 2022 | OGEN OragenicsBiotechnology | SEC FORM 4 Bought | $21K59,053 at $0.35 | filing |
News
No headline names them, or the companies they trade most, lately.